Optimising analgosedation in ECMO (ECMO-SED), version number 1

  • Research type

    Research Study

  • Full title

    Optimising analgosedation in extracorporeal membrane oxygenation (ECMO) using a co-designed analgosedation protocol

  • IRAS ID

    332457

  • Contact name

    Christopher Remmington

  • Contact email

    christopher.2.remmington@kcl.ac.uk

  • Sponsor organisation

    King's College London

  • Clinicaltrials.gov Identifier

    n/a, n/a

  • Duration of Study in the UK

    2 years, 3 months, 6 days

  • Research summary

    Sedation (painkillers and sedative medication) treats pain, reduces suffering, and helps patients in intensive care (ICU) receiving extracorporeal membrane oxygenation (ECMO) remain comfortable. ECMO is a life support machine used in very sick patients with severe heart or lung failure. These patients are younger and generally healthier compared to other critically ill patients. However, patients that survive ECMO have long-term health problems. These include anxiety, memory problems, withdrawal from medicines, and mobility issues. These problems issues could all be related to the type and amount of sedation given.

    A sedation protocol is a way of guiding healthcare professionals how much sedation medication is given to patients in ICU. Too much sedation can cause confusion, hallucinations, excessive sleepiness, and longer time in hospital. Too little sedation can cause pain, distress, and longer time in hospital. There are no protocols for giving sedation to ECMO patients in research papers. We know healthcare staff find it difficult to manage sedation, and higher amounts of sedation is given to ECMO patients.

    The study will be split into two stages and answer the following questions:

    1. What are the current UK practices in sedation management in ECMO centres?
    2. Is a co-designed sedation protocol acceptable to ECMO survivors and family and healthcare professionals?

    National Institute for Health and Care Research (NIHR) is funding the study as part of a Doctoral Clinical Academic and Practitioner Fellowship (NIHR304092).

  • REC name

    Yorkshire & The Humber - South Yorkshire Research Ethics Committee

  • REC reference

    25/YH/0127

  • Date of REC Opinion

    5 Aug 2025

  • REC opinion

    Further Information Favourable Opinion